ALK and small cell lung carcinoma: The mechanisms of resistance targeting ALK rearrangements include genomic alterations, in particular but not exclusively, mutations in ALK that differ according to the treatment, as well as other cellular mechanisms such as transformation into a small cell lung carcinoma or epithelial-mesenchymal transition (EMT) [29,30,31,32].